Keyphrases
Pathologic Myopia
100%
Myopic Choroidal Neovascularization (mCNV)
100%
Verteporfin Photodynamic Therapy
100%
Juxtarenal
100%
Photodynamic Therapy
85%
Ophthalmologist
57%
Verteporfin
42%
High Myopia
28%
Best-corrected Visual Acuity
28%
Patient Expectations
14%
United Kingdom
14%
Hong Kong
14%
Adverse Effects
14%
National Institute for Clinical Excellence
14%
Scar
14%
Vision Loss
14%
Enlargement
14%
Macular
14%
Photocoagulation
14%
Fovea
14%
Standard of Care
14%
Family Support
14%
Rapid Improvement
14%
Subfoveal
14%
Laser Photocoagulation
14%
Undertreatment
14%
Submacular Surgery
14%
Infusion Treatment
14%
Juggling
14%
Creepage
14%
Therapy Treatment
14%
Laser Therapy
14%
Successful Case
14%
Regrowth
14%
Highly Myopic Eyes
14%
Transplantation Surgery
14%
Transpupillary Thermotherapy
14%
Nursing and Health Professions
Subretinal Neovascularization
100%
Verteporfin
100%
Photochemotherapy
100%
Ophthalmologist
44%
High Myopia
22%
Laser Coagulation
22%
Best Corrected Visual Acuity
22%
Deterioration
11%
Health Care Quality
11%
Practice Guideline
11%
Adverse Event
11%
Transplantation
11%
Cohort Analysis
11%
Minoxidil
11%
Transpupillary Thermotherapy
11%
Low Level Laser Therapy
11%
Infusion
11%
Medicine and Dentistry
Verteporfin
100%
Choroidal Neovascularization
100%
Photochemotherapy
100%
High Myopia
22%
Laser Coagulation
22%
Best Corrected Visual Acuity
22%
Infusion
11%
Deterioration
11%
Prospective Study
11%
Adverse Event
11%
Transplantation
11%
Cohort Analysis
11%
Low Level Laser Therapy
11%
Minoxidil
11%
Transpupillary Thermotherapy
11%